ReviewFrontiers in immunology2026

Bispecific antibody-drug conjugates in cancer: therapeutic-window determinants, tumour-immune interactions, and clinical translation.

Yang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.